Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

global access

- PMLiVE

Lundbeck losses deepen on EU fine

Pay-for-delay penalty contributes to operating loss of 506m Danish krone

- PMLiVE

Mobile campaign aims to tackle childhood obesity

OpenMarket to run programme for Blue Cross of Idaho Foundation

- PMLiVE

GSK submits Votrient for ovarian cancer in Europe

Pharma company hopes for extra indication for oncology product

- PMLiVE

Matt Foster leaves H+K for Waggener Edstrom

Joins UK healthcare team as account director

Bayer symbol

Bayer moves closer to US approval of PAH drug riociguat

FDA panel votes unanimously in favour of hypertension treatment

- PMLiVE

Currencies hit Merck Serono sales but firm says it is ‘on course’

Overall groups sales down to €2.84bn for second quarter of 2013

Novartis building

Novartis says Afinitor fails liver cancer trial

Halts plans to file for approval in new indication

- PMLiVE

Elite Pharma names Actavis VP as CEO

Nasrat Hakim also has senior experience at Watson and Alpharma

- PMLiVE

FDA panel turns down Otsuka’s drug for rare kidney disease

Unable to recommend expanded use of tolvaptan

Roche's Perjeta pertuzumab

Roche’s breast cancer drug too expensive for NHS use

But pharma company says UK Government dithering on Perjeta patient access scheme

- PMLiVE

Sanofi vaccine against GI ‘superbug’ starts phase III

Aims to protect against Clostridium difficile

- PMLiVE

Roche loses Herceptin patents in India

Government says pharma company did not follow correct filing procedure

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links